De Rosa, P.; Severi, F.; Zadran, S.K.; Russo, M.; Aloisi, S.; Rigamonti, A.; Capranico, G.; Milazzo, G.; Perini, G.
MYCN Amplification, along with Wild-Type RB1 Expression, Enhances CDK4/6 Inhibitors’ Efficacy in Neuroblastoma Cells. Int. J. Mol. Sci. 2023, 24, 5408.
https://doi.org/10.3390/ijms24065408
AMA Style
De Rosa P, Severi F, Zadran SK, Russo M, Aloisi S, Rigamonti A, Capranico G, Milazzo G, Perini G.
MYCN Amplification, along with Wild-Type RB1 Expression, Enhances CDK4/6 Inhibitors’ Efficacy in Neuroblastoma Cells. International Journal of Molecular Sciences. 2023; 24(6):5408.
https://doi.org/10.3390/ijms24065408
Chicago/Turabian Style
De Rosa, Piergiuseppe, Federica Severi, Suleman Khan Zadran, Marco Russo, Sara Aloisi, Alberto Rigamonti, Giovanni Capranico, Giorgio Milazzo, and Giovanni Perini.
2023. "MYCN Amplification, along with Wild-Type RB1 Expression, Enhances CDK4/6 Inhibitors’ Efficacy in Neuroblastoma Cells" International Journal of Molecular Sciences 24, no. 6: 5408.
https://doi.org/10.3390/ijms24065408
APA Style
De Rosa, P., Severi, F., Zadran, S. K., Russo, M., Aloisi, S., Rigamonti, A., Capranico, G., Milazzo, G., & Perini, G.
(2023). MYCN Amplification, along with Wild-Type RB1 Expression, Enhances CDK4/6 Inhibitors’ Efficacy in Neuroblastoma Cells. International Journal of Molecular Sciences, 24(6), 5408.
https://doi.org/10.3390/ijms24065408